Rs216013

From SNPedia
Jump to: navigation, search

is asnp
is mentioned by
dbSNPrs216013
nextbiors216013
hapmaprs216013
1000 genomesrs216013
hgdprs216013
ensemblrs216013
gopubmedrs216013
scholarrs216013
googlers216013
pharmgkbrs216013
gwascentralrs216013
openSNPrs216013
23andMers216013
23andMe allrs216013
SNP Nexus

SNPshotrs216013
SNPdbers216013
MSV3drs216013
GeneCACNA1C
Chromosome12
Orientationplus
Position2729632
ReferenceGRCh37 37.1/131
Max Magnitude
Make rs216013(A;A)
Make rs216013(A;G)
Make rs216013(G;G)
? (A;A) (A;G) (G;G) 28
influences warfarin dose
GWAS
SNP rs216013
PubMedID [PMID 18535201]
Condition Warfarin maintenance dose
Gene CACNA1C
Risk Allele
pValue 9.00E-007
OR NA
95% CI


PharmGKBPA165110432
Name
AnnotationThis intronic variant in the membrane calcium-channel gene CACNA1C was correlated with warfarin dose (p = 9.2 × 10−5) in the index population (n = 181) from a GWAS study of white patients undergoing anticoagulation therapy. Combined analysis of the index and replication populations (n = 374) yielded a p value of 8.6 × 10−7. "However, this variant did not reach established significance threshold independently in the replication population (P = .002), nor did it achieve significance after multiple testing correction in multivariate modeling (uncorrected P = .003)".
GeneCACNA1C
Featue
EvidencePubMed ID:18535201
Drugswarfarin
Diseases
Curation LevelCurated
PharmGKBPA162356395
Name
AnnotationGWAS results: A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose (Initial Sample Size: 181 individuals; Replication Sample Size: 374 individuals). This variant is associated with Warfarin maintenance dose.
GeneCACNA1C
Featue
EvidencePubMed ID:18535201; Web Resource:http://www.genome.gov/gwastudies/
Drugswarfarin
Diseases
Curation LevelNon-Curated
Personal tools
Namespaces
Variants
Actions
Navigation
Toolbox